SecBot SecBot
6-K ·Filed Oct 7, 2026

CUVL

Clinuvel Pharmaceuticals Ltd
NEUTRAL
Impact 2/10
Horizonimmediate Processed20d 15h ago SEC0001493152-26-046056
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine securities housekeeping filing with the ASX. No immediate trading catalyst. Monitor subsequent ASX announcements for details on the specific securities changes.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
CUVL ▼ -8.62% at T+5d
NEUTRAL call -8.62% · α vs SPY -7.64% · entry $5.80 → $5.30
Next anchor: T+20d in 7d
Latest observation: T+12 -15.48% FF3 residual α
Entry = T+0 close
Oct 7, 2026
via day close
T+1d
-3.45%
call -3.45% · α -3.02%
$5.60
settled 20d ago
T+5d
-8.62%
call -8.62% · α -7.64%
$5.30
settled 14d ago
T+20d
Pending
in 7d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Clinuvel Pharmaceuticals Ltd filed a Form 6-K with the SEC on October 7, 2026, reporting that on October 5, 2026, it filed an application for quotation of securities, a notification of cessation of securities, and a Section 708A cleansing statement with the Australian Securities Exchange. This is a routine administrative filing related to the company's securities on the ASX, with no financial data or material corporate events disclosed.

Key Facts

  • Filed on October 7, 2026, for the month of October 2026
  • Reports filing of Appendix 2A (Application for quotation of securities), Appendix 3H (Notification of cessation of securities), and Section 708A Cleansing Statement with the ASX on October 5, 2026
  • No financial figures, revenue, earnings, or material business developments disclosed

Financial Impact

No financial impact disclosed in the filing

Risk Factors

  • No material risks disclosed in this filing

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001493152-26-046056
Document: 0001493152-26-046056-index-headers.html0001493152-26-046056
Document: 0001493152-26-046056-index.html0001493152-26-046056
Document: 0001493152-26-046056.txt0001493152-26-046056
8 reports for CUVL
Performance horizon
Filters
Rows
Reports for CUVL — sortable, filterable
TypeNow
Oct 15, 2026
12d ago
6-K
NEUTRAL ★ 2/10
$5.06awaiting T+20—$5.02 (−0.79%)
Oct 7, 2026
20d ago
6-K
NEUTRAL ★ 2/10
$5.80awaiting T+20—$5.02 (−13.45%)
Oct 2, 2026
25d ago
6-K
NEUTRAL ★ 2/10
$6.03awaiting T+20—$5.02 (−16.75%)
Oct 1, 2026
26d ago
6-K
NEUTRAL ★ 3/10
$5.66awaiting T+20—$5.02 (−11.31%)
Aug 27, 2026
8w ago
6-K
NEUTRAL ★ 3/10
$6.77 $5.78▼ −14.62%▼ −14.12%$5.02 (−25.85%)
Aug 27, 2026
8w ago
Press Release
MIXED ★ 5/10
$6.77 $5.78▼ −14.62%▼ −14.12%$5.02 (−25.85%)
Aug 20, 2026
9w ago
6-K
NEUTRAL ★ 2/10
$7.80 $5.90▼ −24.36%▼ −24.36%$5.02 (−35.64%)
Jul 23, 2026
13w ago
6-K
MIXED ★ 5/10
$6.95 $7.80▲ +12.23%▲ +8.92%$5.02 (−27.77%)
Showing 8 of 8

US Market Status

Market Closed — Opens Thu (11h 47m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 7, 2026